Literature DB >> 30917327

Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site.

Simona Selberg1, Daria Blokhina2, Maria Aatonen3, Pertti Koivisto4, Antti Siltanen2, Eero Mervaala2, Esko Kankuri2, Mati Karelson5.   

Abstract

Chemical modifications of RNA provide an additional, epitranscriptomic, level of control over cellular functions. N-6-methylated adenosines (m6As) are found in several types of RNA, and their amounts are regulated by methyltransferases and demethylases. One of the most important enzymes catalyzing generation of m6A on mRNA is the trimer N-6-methyltransferase METTL3-14-WTAP complex. Its activity has been linked to such critical biological processes as cell differentiation, proliferation, and death. We used in silico-based discovery to identify small-molecule ligands that bind to METTL3-14-WTAP and determined experimentally their binding affinity and kinetics, as well as their effect on enzymatic function. We show that these ligands serve as activators of the METTL3-14-WTAP complex.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  N-6-methyladenosine; N6-adenosine-methyltransferases; RNA methylation; computer-aided design; epitranscriptomics; ligand binding

Mesh:

Substances:

Year:  2019        PMID: 30917327     DOI: 10.1016/j.celrep.2019.02.100

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  45 in total

Review 1.  Epitranscriptomic regulation by m6A RNA methylation in brain development and diseases.

Authors:  Anil K Chokkalla; Suresh L Mehta; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-23       Impact factor: 6.200

2.  The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling.

Authors:  Jinjin Yu; Lujun Shen; Yanli Liu; Hong Ming; Xinxing Zhu; Maoping Chu; Juntang Lin
Journal:  Mol Cell Biochem       Date:  2019-10-23       Impact factor: 3.396

Review 3.  Role of circular RNAs in brain development and CNS diseases.

Authors:  Suresh L Mehta; Robert J Dempsey; Raghu Vemuganti
Journal:  Prog Neurobiol       Date:  2020-01-10       Impact factor: 11.685

4.  Proteome-wide Interrogation of Small GTPases Regulated by N6-Methyladenosine Modulators.

Authors:  Yen-Yu Yang; Kailin Yu; Lin Li; Ming Huang; Yinsheng Wang
Journal:  Anal Chem       Date:  2020-07-07       Impact factor: 6.986

Review 5.  RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.

Authors:  Subhadra Kumari; Santosh Kumar; Srinivasan Muthuswamy
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.553

Review 6.  Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS.

Authors:  Anil K Chokkalla; Suresh L Mehta; Raghu Vemuganti
Journal:  Transl Stroke Res       Date:  2021-07-05       Impact factor: 6.829

Review 7.  Regulation of RNA N6-methyladenosine modification and its emerging roles in skeletal muscle development.

Authors:  Jiju Li; Yangli Pei; Rong Zhou; Zhonglin Tang; Yalan Yang
Journal:  Int J Biol Sci       Date:  2021-04-12       Impact factor: 6.580

8.  METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.

Authors:  Fei Li; Jing Zhao; Lei Wang; Yantong Chi; Xiaori Huang; Wei Liu
Journal:  Mol Biotechnol       Date:  2021-09-29       Impact factor: 2.695

9.  m6A modification regulates lung fibroblast-to-myofibroblast transition through modulating KCNH6 mRNA translation.

Authors:  Jia-Xiang Zhang; Pei-Jie Huang; Da-Peng Wang; Wen-Yu Yang; Jian Lu; Yong Zhu; Xiao-Xiao Meng; Xin Wu; Qiu-Hai Lin; Hui Lv; Hui Xie; Rui-Lan Wang
Journal:  Mol Ther       Date:  2021-06-08       Impact factor: 11.454

Review 10.  From A to m6A: The Emerging Viral Epitranscriptome.

Authors:  Belinda Baquero-Perez; Daryl Geers; Juana Díez
Journal:  Viruses       Date:  2021-06-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.